FDA Commissioner Andrew von Eschenbach defended his agency's cooperation with drug companies as important for the development of new drugs. Some lawmakers have criticized the agency for being too close to pharmaceutical firms, but von Eschenbach said, "We want drug companies to get it right from the very beginning."

Full Story:

Related Summaries